Point72 Hong Kong’s Fulgent Genetics FLGT Stock Holding History

Point72 Hong Kong’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-810	Closed	-$78K	–	2058
2021 Q1	$78K	Buy	+810	New	+$83.6K	﹤0.01%	1206
2016 Q4	–	Sell	-7,200	Closed	-$66K	–	919
2016 Q3	$66K	Buy	+7,200	New	+$66.2K	0.04%	415

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Point72 Hong Kong's FLGT Position: Q2 2021 in Review

Point72 Hong Kong sold out of Fulgent Genetics (FLGT) in Q2 2021, closing a stake of 810 shares — an estimated $78K sold.

Point72 Hong Kong first reported a position in FLGT in Q3 2016 and held it in 2 quarters. The position peaked at $78K in Q1 2021. 254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

Point72 Hong Kong reported no remaining Fulgent Genetics position as of Q2 2021 after selling out during the quarter.
Point72 Hong Kong sold 810 Fulgent Genetics shares in Q2 2021, an estimated $78K.
Point72 Hong Kong first reported a position in Fulgent Genetics in Q3 2016 and held it in 2 quarters.
Point72 Hong Kong's Fulgent Genetics position peaked at $78K in Q1 2021.
254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.